Mutant KRAS Promotes NKG2D(+) T Cell Infiltration and CD155 Dependent Immune Evasion. Nishi K, Ishikura S, Umebayashi M, Morisaki T, et al. Anticancer Res 2020;40:4663-4674.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nishi K, Ishikura S, Umebayashi M, Morisaki T, et al. Mutant KRAS Promotes NKG2D(+) T Cell Infiltration and CD155 Dependent Immune Evasion. Anticancer Res 2020;40:4663-4674.
PMID: 32727790